
7-Hydroxycarbostyril
CAS No. 70500-72-0
7-Hydroxycarbostyril ( 3,4-Dihydro-7-hydroxycarbostyril )
产品货号. M27524 CAS No. 70500-72-0
7-羟基喹诺酮(3,4-二氢-7-羟基喹诺酮)是一种医药中间体。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥413 | 有现货 |
![]() ![]() |
25MG | ¥632 | 有现货 |
![]() ![]() |
50MG | ¥956 | 有现货 |
![]() ![]() |
100MG | ¥1426 | 有现货 |
![]() ![]() |
200MG | ¥2147 | 有现货 |
![]() ![]() |
500MG | ¥3216 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称7-Hydroxycarbostyril
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述7-羟基喹诺酮(3,4-二氢-7-羟基喹诺酮)是一种医药中间体。
-
产品描述7-Hydroxycarbostyril (3,4-Dihydro-7-hydroxycarbostyril) is a kind of pharmaceutical intermediate.(In Vitro):?VPC-80051 as the first small molecule inhibitor of hnRNP A1 splicing activity discovered to date by using a computer-aided drug discovery approach. The inhibitor was developed to target the RNA-binding domain (RBD) of hnRNP A1. Further experimental evaluation demonstrated that VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line. This study lays the groundwork for future structure-based development of more potent and selective small molecule inhibitors of hnRNP A1?RNA interactions aimed at altering the production of cancer-specific alternative splice isoforms.
-
体外实验——
-
体内实验——
-
同义词3,4-Dihydro-7-hydroxycarbostyril
-
通路Others
-
靶点Other Targets
-
受体TRPA1
-
研究领域——
-
适应症——
化学信息
-
CAS Number70500-72-0
-
分子量161.16
-
分子式C9H7NO2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc1ccc2ccc(O)nc2c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Takaya J, et al. A Potent and Site-Selective Agonist of TRPA1. J Am Chem Soc. 2015 Dec 23;137(50):15859-64.
产品手册




关联产品
-
LY-294002 hydrochlor...
LY294002 是 PI3Kα/δ/β 的合成分子抑制剂(IC50:0.5/0.57/0.97 μM,无细胞测定);在溶液中比渥曼青更稳定,也是自噬体形成的阻断剂。
-
11-O-Galloylbergenin
11-O-没食子酰白菜素具有良好的抗氧化和抗疟原虫活性,在大鼠福尔马林试验中,在20和40 mg/kg剂量下显示出显着的镇痛活性,在角叉菜胶诱导的足水肿模型中,在剂量为10、20和30毫克/公斤。
-
2-Acetamidophenyl 5-...
磷酸二酯酶7抑制剂。